NEW YORK (Reuters Health) – Women with early breast cancer who are poorly represented in clinical trials experience poorer survival than their well-represented peers, according […] Oncologists at the University of San Francisco, California (UCSF) are calling for this year’s San Antonio Breast Cancer Symposium (SABCS) to be moved out of […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Breast cancer screening rates at community health centers (CHCs) in the […] Long-term results give a resounding yes to the question of whether radiotherapy reduces the risk of recurrence over observation alone in women with good-risk ductal […] Oncotarget published "Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity" which reported […] A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according […] No link between fertility treatment and an increase in the risk for breast cancer was found in the largest study of the issue to date. […] In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for […] New research from UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately […] NEW YORK (Reuters Health) – Longer-term follow-up data from the MINDACT trial confirm the clinical utility of the 70-gene MammaPrint assay to help guide chemotherapy […]
Poor Representation in Breast Cancer Clinical Trials Tied to Real-World Harms
Call for a Move or Boycott of Big Texas Cancer Meeting
Drops in Breast Cancer Screening Hit Underserved
Radiotherapy in Good-Risk DCIS ‘Definitely Worth Doing’
New insights on replication-stress sensitivity in breast cancer cells
Biomarker shows potential to predict immunotherapy benefit for breast cancer patients
No Increase in Breast Cancer Risk With Fertility Treatments
Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients
New study could revive once-promising immunotherapies for treating solid tumors
Follow-Up Supports MammaPrint to Guide Chemo Decisions, Points to an ‘Age Effect’
Copyright © 2023